Login

M.S. Cohen

ORCID: 0000-0003-1765-0280
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5028622167
Research Areas
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV, TB, and STIs Epidemiology
  • HIV/AIDS oral health manifestations

Fundação Oswaldo Cruz
 2024

Instituto Evandro Chagas
 2024

 Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy
OPENALEX - Publications 
M.S. Cohen Olivia D. Council J.S. Chen

10.17615/f894-5760 article EN cc-by Carolina Digital Repository (University of North Carolina at Chapel Hill) 2019-01-01
 Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
OPENALEX - Publications 
Cristina Pimenta Thiago S. Torres Brenda Hoagland M.S. Cohen Claudio Gruber Mann and 12 more Cristina Moreira Jalil Eduardo Carvalheira Netto Lucilene Freitas Nilo Martinez Fernandes Débora Castanheira Marcos Benedetti Júlio Moreira Keila Simpson Roberta Trefiglio Gabrielle O’Malley Valdiléa G. Veloso Beatriz Grinsztejn

Background Although long-acting, injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention in clinical trials, research is needed to guide effective implementation real-world settings. Formative work with community members and health care providers (HCPs) important provide insight into the needs contexts of specific populations reveal potential barriers facilitators projects. Objective We aimed describe results from formative develop an...

10.2196/60961 article EN cc-by JMIR Public Health and Surveillance 2024-10-24
 Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study (Preprint)
OPENALEX - Publications 
Cristina Pimenta Thiago S. Torres Brenda Hoagland M.S. Cohen Claudio Gruber Mann and 12 more Cristina Moreira Jalil Eduardo Carvalheira Netto Lucilene Freitas Nilo Martinez Fernandes Débora Castanheira Marcos Benedetti Júlio Moreira Keila Simpson Roberta Trefiglio Gabrielle O’Malley Valdiléa G. Veloso Beatriz Grinsztejn

<sec> <title>BACKGROUND</title> Although long-acting, injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention in clinical trials, research is needed to guide effective implementation real-world settings. Formative work with community members and health care providers (HCPs) important provide insight into the needs contexts of specific populations reveal potential barriers facilitators projects. </sec> <title>OBJECTIVE</title> We aimed...

10.2196/preprints.60961 preprint EN 2024-05-27
 Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States: A Cost-Effectiveness Analysis
OPENALEX - Publications 
Anne M. Neilan R.J. Landovitz M.H. Le B. Grinsztejn K. A. Freedberg and 9 more M. McCauley Nattanicha Wattananimitgul M.S. Cohen Andrea Ciaranello Meredith E. Clement Krishna P. Reddy Emily P. Hyle A. David Paltiel Rochelle P. Walensky

10.17615/6n7p-mj28 article EN Carolina Digital Repository (University of North Carolina at Chapel Hill) 2022-01-01
 Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial
OPENALEX - Publications 
J.M. Fogel S.E. Hudelson S.-S. Ou S. Hart C. Wallis and 28 more Micaela Morgado S. Saravanan S. Tripathy L. Hovind E. Piwowar-Manning D. Sabin M. McCauley T. Gamble X.C. Zhang J.J. Eron J.E. Gallant J. Kumwenda J. Makhema N. Kumarasamy S. Chariyalertsak J. Hakim S. Badal-Faesen V. Akelo M.C. Hosseinipour B.R. Santos S.V. Godbole José Henrique Pilotto B. Grinsztejn R. Panchia K.H. Mayer Y.Q. Chen M.S. Cohen S.H. Eshleman

10.17615/f2jz-6j31 article EN Carolina Digital Repository (University of North Carolina at Chapel Hill) 2016-01-01
 Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
OPENALEX - Publications 
M.A. Marzinke J.M. Fogel Zhen Wang E. Piwowar-Manning R. Kofron and 24 more Auristela Duarte de Lima Moser Prasha Bhandari Ryann Gollings L.R. Bushman Lei Weng Elias K. Halvas John W. Mellors Peter L. Anderson D. Persaud C.W. Hendrix M. McCauley A.R. Rinehart Marty St. Clair S.L. Ford J.F. Rooney A. Adeyeye S. Chariyalertsak Kenneth H. Mayer R.C. Arduino M.S. Cohen Beatriz Grinsztejn Brett Hanscom R.J. Landovitz S.H. Eshleman

10.17615/tc7d-x473 article EN cc-by Carolina Digital Repository (University of North Carolina at Chapel Hill) 2023-01-01
 Virologic outcomes in early antiretroviral treatment: HPTN 052
OPENALEX - Publications 
S.H. Eshleman E.A. Wilson X.C. Zhang S.-S. Ou E. Piwowar-Manning and 21 more J.J. Eron M. McCauley T. Gamble J.E. Gallant M.C. Hosseinipour N. Kumarasamy J.G. Hakim B. Kalonga José Henrique Pilotto B. Grinsztejn S.V. Godbole N. Chotirosniramit B.R. Santos E. Shava L.A. Mills R. Panchia N. Mwelase K.H. Mayer Y.Q. Chen M.S. Cohen J.M. Fogel

10.17615/tbkz-rg13 article EN Carolina Digital Repository (University of North Carolina at Chapel Hill) 2017-01-01
 Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
OPENALEX - Publications 
S. Delany-Moretlwe J.P. Hughes Paul Bock Samuel Gurrion Ouma Portia Hunidzarira and 35 more Dishiki Kalonji Noel Kayange J. Makhema Patricia Mandima Christopher G. Mathew Elizabeth Spooner Juliet Mpendo Pamela Mukwekwerere Nyaradzo Mgodi Patricia Nahirya Ntege Gonasagrie Nair C. Nakabiito Harriet Nuwagaba‐Biribonwoha R. Panchia Nanak Singh Bekezela Siziba Jennifer Farrior Scott Rose Peter L. Anderson S.H. Eshleman M.A. Marzinke C.W. Hendrix Stephanie Beigel-Orme Sybil Hosek E. Tolley Nirupama Sista A. Adeyeye J.F. Rooney A. Rinehart W.R. Spreen M. Kumi Smith Brett Hanscom M.S. Cohen M.C. Hosseinipour HPTN study group

10.17615/9m9q-rf23 article EN cc-by Carolina Digital Repository (University of North Carolina at Chapel Hill) 2022-01-01
 HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
OPENALEX - Publications 
S.H. Eshleman J.M. Fogel Elias K. Halvas E. Piwowar-Manning Mark A. Marzinke and 15 more R. Kofron Zhiqiang Wang John W. Mellors M. McCauley Alex R. Rinehart Marty St. Clair A. Adeyeye Juan Hinojosa Robinson Cabello Keren Middelkoop Brett Hanscom M.S. Cohen Beatriz Grinsztejn R.J. Landovitz HPTN Study Team

10.17615/vg56-mv82 article EN Carolina Digital Repository (University of North Carolina at Chapel Hill) 2022-01-01
 A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings
OPENALEX - Publications 
Nyaradzo Mgodi Simbarashe Takuva Srilatha Edupuganti Shelly Karuna P. Andrew and 24 more Erica Lazarus Precious Garnett E. Shava Pamela Mukwekwerere Nidhi Kochar Katherine L. Marshall Erika Rudnicki Michal Juraska Mark Anderson Christian Karg India Tindale Ernest R. Greene Nokuzola Dorcas Luthuli Kagisho Baepanye John Hural Gomez Lorenzo David Burns Maurine D. Miner J. Ledgerwood John R. Mascola Deborah Donnell M.S. Cohen Lawrence Corey the HVTN HPTN Team

10.17615/42e2-fv64 article EN Carolina Digital Repository (University of North Carolina at Chapel Hill) 2021-01-01
Coming Soon ...